Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Mar 2011 - Clin. Cancer Res.; 17(6):1078-0432 [PMID:21135147] [Prins RM] [Soto H] [Konkankit V] [Odesa SK] [Eskin A] [Yong WH] [Nelson SF] [Liau LM]
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Aug 2005 - Clin. Cancer Res.; 11(15):1078-0432 [PMID:16061868] [Liau LM] [Prins RM] [Kiertscher SM] [Odesa SK] [Kremen TJ] [Giovannone AJ] [Lin JW] [Chute DJ] [Mischel PS] [Cloughesy TF] [Roth MD]
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Feb 2001 - Cancer Res.; 61(3):0008-5472 [PMID:11221866] [Yu JS] [Wheeler CJ] [Zeltzer PM] [Ying H] [Finger DN] [Lee PK] [Yong WH] [Incardona F] [Thompson RC] [Riedinger MS] [Zhang W] [Prins RM] [Black KL]
